The Liddy Shriver Sarcoma Initiative helping those dealing with sarcoma.                      HOME
Liddy's Story
Sarcomas
Clinical Trials
ESUN
Funded Research
Sarcoma Calendar
Initiatives
Personal Journeys
Links
News
Donations
Volunteer
First Time Visitors
Searching Our Website
Guest Book

Up

Jean-Yves Blay, M.D., Ph.D. and Denise Reinke, APRN, BC, AOCN Join Medical Editorial Board.

 

by Bruce Shriver

 

We are pleased to announce that a distinguished physician and a distinguished sarcoma nurse practitioner have joined our Medical Editorial Advisory Board. We look forward to the contributions they will make to ESUN.

 

Jean-Yves Blay, MD, PhD 

Jean-Yves Blay, MD, PhD, is a Professor of Medicine at the Université Claude Bernard in Lyon, France and the Scientific Director of the Cancéropôle Lyon Rhône-Alpes, a network of more than 1500 researchers and physicians in the French Rhône-Alpes region bridging clinical, translational and basic research in oncology. Dr. Blay received a medical degree and a doctorate from the Université Claude Bernard and completed a fellowship in oncology and internal medicine at Université Claude Bernard Lyon 1 and the Institut Gustave-Roussy in Paris. He subsequently joined the staff of the Comprehensive Cancer Center Leon Berard in Lyon, ultimately becoming Head of the Cytokine and Cancer Unit within an Institut National de la Santé et de la Recherche Médicale (INSERM) research unit. He assumed the position as Head of the Medical Oncology Unit in University Hospital in Lyon in 1999, becoming Scientific Director of Cancéropôle Lyon Rhône-Alpes in 2004. Dr. Blay’s research interests center on clinical and biological research in the field of soft tissue sarcomas, as well as on the biology of breast carcinoma and the relationship between tumor microenvironment and malignant cells, with the ultimate goal of clinical applications in the fields of diagnosis, prognosis, and treatment. Dr. Blay’s professional endeavors mirror his research interests. He is a contributor to the medical literature and has more than 150 peer-reviewed articles and over 200 abstracts and book chapters to his credit. Writing for such journals as Blood, Cancer, Annals of Oncology, Journal of Clinical Oncology, and the European Journal of Cancer, he addresses a range of subjects that includes the role of interleukins, sarcomas of the soft tissues, and the role of dendritic cells in boosting antitumor response. Dr. Blay is active in numerous professional organizations, most prominently the European Organization for Research and Treatment of Cancer (EORTC), of which he is currently Chairman of the Soft Tissue and Bone Sarcoma Group, Vice Chairman of the Translational Research Advisory Committee, and member of the Protocol Review Committee. He is the Chairman of the Strategic Clinical Research Committee of the French Federation of Cancer Centers and Current Chairman of the Connective Tissue Cancers Network (CONTICANET) Network of Excellence supported by the Sixth Framework Program of the European Commission. Dr. Blay is the National Representative for the European Society for Medical Oncology (ESMO) and an active member of the American Society of Clinical Oncology (ASCO) and the American Association for Cancer Research (AACR). Additionally, he has served as a member of scientific committees for ESMO and AACR meetings.

 

Denise Reinke, APRN, BC, AOCN

Denise Reinke is a Sarcoma Nurse Practitioner at the University of Michigan Comprehensive Cancer Center and is the Administrative Director of SARC (Sarcoma Alliance for Research through Collaboration, see the sidebar below). She has been a  nurse for 31 years and has spent 29 of those years caring for people with cancer in a variety of settings.  Her first oncology experience was as a nurse in radiation oncology in the 1970s when oncology nursing as a subspecialty was in its infancy. Over the years, she has established an outpatient oncology program within a health maintenance organization, worked as part of a bone marrow transplant team, was a nurse practitioner in a private hematology/oncology practice, and worked as a medical science liaison for a pharmaceutical company. For the past 5 years, she has been working collaboratively with Dr. Larry Baker at the University of Michigan (see ESUN June 2006 article). One of Dr. Baker’s visions has been to bring together a group of sarcoma specialists to collaborate on clinical trials for patients with sarcoma. Hence, the formation of SARC, a non-for-profit organization with the mission and vision to facilitate the collaborative sarcoma research endeavors of not only physicians within the United States but in Europe as well. Denise provides administrative oversight for this collaboration. She received her Master of Science degree from the University of Michigan, Bachelor of Science in nursing from Alverno College, Milwaukee, Wisconsin, and diploma in nursing from Milwaukee County School of Nursing. She is a member of the national Oncology Nursing Society and president of the Ann Arbor local chapter of the Oncology Nursing Society. Additionally, Denise is a member of ASCO and the American Academy of Nurse Practitioners. She has recently coauthored publications on standing orders for nursing care of cancer patients and on a collaborative cancer clinical trial. Denise has facilitated the collaborative translation of the NCCN sarcoma guidelines and have provided editorial oversight for this project which is being spearheaded by sarcoma nurses in SARC. She has been a guest lecturer at 4 major conferences this past year, providing information and updates on sarcoma diagnosis and treatment. Denise is starting a new, regular column for ESUN called, "From a Nurse's Perspective", which will launch in our first issue in 2007.

 

SARC

SARC, the Sarcoma Alliance for Research through Collaboration, is a non-for-profit consortium with a mission to conduct clinical trials to improve the diagnosis and treatment of sarcoma, and to ultimately find a cure for this disease. SARC includes participants from 20 institutions with many physicians from various diagnostic and therapeutic disciplines whose practices are limited to sarcoma. In addition, SARC is committed to providing accurate and up-to-date information about sarcoma to physicians, patients and families affected by the disease. To participate in SARC, physicians must be part of a multidisciplinary sarcoma practice that includes expertise in diagnosis (pathology and radiology physicians) and treatment (pediatric, medical, radiation, surgical and orthopedic oncologist) of sarcoma. In addition, participants must have a commitment to research and a practice that sees at least 150 new sarcoma cases per year. SARC participants are committed to the CTOS (Connective Tissue Oncology Society) model and philosophy that sarcoma’s are best studied and managed in a collaborative fashion. While pooling intellectual resources, SARC also strives to pool patient resources

 

V3N6 ESUN Copyright © 2006 Liddy Shriver Sarcoma Initiative.